文献速递类风湿关节炎

两成分DAS28潜在类别轨迹建模识别类风湿关节炎生物制剂反应的多种表型

Latent Class Trajectory Modeling of 2-Component Disease Activity Score in 28 Joints Identifies Multiple Rheumatoid Arthritis Phenotypes of Response to Biologic Disease-Modifying Antirheumatic Drugs.
PubMed 文献 · Arthritis Rheumatol · 2020-09-06

在2991例类风湿关节炎患者中,采用潜在类别混合模型比较四成分与两成分DAS28定义的生物制剂治疗反应轨迹。四成分DAS28识别3个轨迹组并反映抑郁信息;两成分DAS28识别7个轨迹组,区分出呼吸道合并症及抗药抗体事件较多的无应答组和依从性差但评分较低组。两成分DAS28可定义与治疗结局相关的重要生物学和临床表型。

要点

  • 两成分DAS28识别出7个轨迹组,多于四成分DAS28的3个组。
  • 两成分DAS28区分出无应答组,其呼吸道合并症和抗药抗体事件更多。
  • 四成分DAS28捕获抑郁相关信息,两成分DAS28捕获依从性差但评分低组。

核心结论

  • 两成分改良DAS28可定义类风湿关节炎中与生物制剂治疗结局相关的重要生物学和临床表型。

研究设计与样本

  • 基于Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate队列中2991例开始生物制剂治疗的类风湿关节炎患者,采用潜在类别混合模型分析。

主要发现

  • 四成分DAS28识别3个轨迹组,并捕获抑郁相关信息。
  • 两成分DAS28识别7个轨迹组,其中无应答组呼吸道合并症发生率更高且抗药抗体事件比例更高。
  • 两成分DAS28还识别出一组评分持续较低的患者,该组治疗不依从比例较高。

临床怎么用

  • 两成分DAS28可用于监测疾病活动性的不同成分,并辅助识别生物制剂治疗反应表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether using a reweighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (DAS28) (based on swollen joint count and C-reactive protein level), produces more clinically relevant treatment outcome trajectories compared to the standard 4-component DAS28. METHODS: Latent class mixed modeling of response to biologic treatment was applied to 2,991 rheumatoid arthritis (RA) patients in whom treatment with a biologic disease-modifying antirheumatic drug was being initiated within the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort, using both 4-component and 2-component DAS28 scores as outcome measures. Patient groups with similar trajectories were compared in terms of pretreatment baseline characteristics (including disability and comorbidities) and follow-up characteristics (including antidrug antibody events, adherence to treatments, and blood drug levels). We compared the trajectories obtained using the 4- and 2-component scores to determine which characteristics were better captured by each. RESULTS: Using the 4-component DAS28, we identified 3 trajectory groups, which is consistent with previous findings. We showed that the 4-component DAS28 captures information relating to depression. Using the 2-component DAS28, 7 trajectory groups were identified; among them, distinct groups of nonresponders had a higher incidence of respiratory comorbidities and a higher proportion of antidrug antibody events. We also identified a group of patients for whom the 2-component DAS28 scores remained relatively low; this group included a high percentage of patients who were nonadherent to treatment. This highlights the utility of both the 4- and 2-component DAS28 for monitoring different components of disease activity. CONCLUSION: Here we show that the 2-component modified DAS28 defines important biologic and clinical phenotypes associated with treatment outcome in RA and characterizes important underlying response mechanisms to biologic drugs.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Dagliati A, Plant D, Nair N, et al. Latent Class Trajectory Modeling of 2-Component Disease Activity Score in 28 Joints Identifies Multiple Rheumatoid Arthritis Phenotypes of Response to Biologic Disease-Modifying Antirheumatic Drugs. Arthritis Rheumatol. 2020. PMID: 32475078. doi:10.1002/art.41379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。